• Jean Chastre, Charles-Edouard Luyt, Jean-Louis Trouillet, and Alain Combes.
• Medical Intensive Care Unit, Pitié-Salpêtrière Hospital, Pierre and Marie Curie University, Paris, France. jean.chastre@psl.aphp.fr
• Curr Opin Crit Care. 2006 Oct 1;12(5):446-51.

Purpose Of ReviewThe purpose of this review is to analyze the potential advantages and drawbacks of using biomarkers of bacterial infection for the diagnosis and prognosis of ventilator-associated pneumonia.Recent FindingsWhereas procalcitonin and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have both greater diagnostic accuracies than most commonly used clinical parameters and other biomarkers of infection, such as C-reactive protein, they can be increased in noninfectious conditions or remain low in patients with true infection. Furthermore, these assays cannot determine the causative organisms and associated patterns of antibiotic susceptibility.SummaryProcalcitonin and sTREM-1 should be used only as a complementary tool, to reinforce the usual diagnostic work-up. However, serial serum procalcitonin and sTREM-1 measurements may provide an opportunity to change the treatment early in the course of patients with ventilator-associated pneumonia, either to intensify treatment when their levels stay high, or to avoid unnecessary prolonged courses of antibiotics when their levels rapidly decrease. Whether procalcitonin and/or sTREM-1 guidance can reduce antibiotic use in such a setting will require additional studies, but such a strategy appears promising.

23 keywords...

hide…